Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2005
10/20/2005US20050234015 Low molecular weight heparin salt with triethanolamine useful as therapeutic-antitrombotic agent of local delivery, procedures for preparing them, process for elimination of hygroscopicity of heparin salt, pharmaceutical compositions for local use in antithrombotic therapy and uses therein
10/20/2005US20050234013 comprising a heparinoid, a local anesthetic agent and a buffering compound
10/20/2005US20050234011 Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233990 Anti-cancer agents comprising disintegrin genes and the treating methods
10/20/2005US20050233968 Polyamino acid-based insulin preparation
10/20/2005US20050233945 Methods for fabrication, uses and compositions of small spherical particles of insulin prepared by controlled phase separation
10/20/2005US20050233301 Cryopreservation of haptenized tumor cells
10/20/2005US20050233074 Solid flowable powder with high liquid loading
10/20/2005US20050233048 Edible film
10/20/2005US20050233006 microbiocide or antiseptic mixtures comprising a Iodine-propylene glycol complex and water, used for treatment of mastitis in cattle; topical
10/20/2005US20050233003 Nanosized particles of salicylic acid wrapped in an amphiphilic polymer of polyacrylic acid, polyacrylamide, polymethacrylamide and polylysine; polymer is modified with urea, nicotinamide or guanidine
10/20/2005US20050233001 Particles of megestrol, megestrol acetate, and surface stabilizer; endometriosis, dysmenorrhea, hirsutism, uterine bleeding, neoplastic diseases, appetite enhancement, contraception
10/20/2005US20050233000 including polymer or gelatin, curing structural material, and dispensing jettable pharmaceutical solution onto cured structural material
10/20/2005US20050232999 Method for producing a chitosan containing salt having a function of lowering blood pressure
10/20/2005US20050232998 Dry powder inhalant composition
10/20/2005US20050232997 Pharmaceutical formulations
10/20/2005US20050232996 Matrix comprising a bioactive component containing phospholipid
10/20/2005US20050232994 Dual-spike release formulation for oral drug delivery
10/20/2005US20050232993 Dosage form containing promethazine and another drug
10/20/2005US20050232992 Proton pump inhibitor formulations, and methods of preparing and using such formulations
10/20/2005US20050232991 Storage stable thyroxine active drug formulations and methods for their production
10/20/2005US20050232990 Donepezil formulations
10/20/2005US20050232989 Process for preparing oral calcium compositions
10/20/2005US20050232988 Orally disintegrating tablets and methods of manufacture
10/20/2005US20050232987 Dosage form containing a morphine derivative and another drug
10/20/2005US20050232986 Dosage form containing promethazine and another drug
10/20/2005US20050232984 Non-vesicular cationic lipid formulations
10/20/2005US20050232983 Transdermal patch
10/20/2005US20050232982 drug layer, support layer insoluble in water comprising ethyl cellulose and hydroxypropyl methylcellulose, backing on support layer, wherein drug layer consists of fentanyl or salt as active ingredient, methyl vinyl ether-maleic anhydride copolymer as adhesive, hydroxypropylcellulose; easily removed
10/20/2005US20050232981 Compositions capable of facilitating penetration across a biological barrier
10/20/2005US20050232978 Delivery system for topical medications
10/20/2005US20050232977 Metered mixing technology for improved taste masking
10/20/2005US20050232974 System and a method for pharmaceutical dosage preparation using jettable microemulsions
10/20/2005US20050232973 Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles
10/20/2005US20050232954 Porous substances and methods for producing the same
10/20/2005US20050232952 Self emulsifying drug delivery systems for poorly soluble drugs
10/20/2005US20050232930 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product
10/20/2005US20050232899 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
10/20/2005US20050232898 Stabilized protein compositions
10/20/2005US20050232879 Antifungal medicinal compositions
10/20/2005US20050232874 Compound and method of treatment for fungal pathologies of the oral cavity
10/20/2005US20050232873 Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
10/20/2005US20050232872 Compositions and methods for enhancing receptor-mediated cellular internalization
10/20/2005US20050232871 Use of compounds in a dry powder inhaler
10/20/2005US20050232870 Method of treatment of dopamine-related dysfunction
10/20/2005US20050229683 Trouble shooting accelerator system for implantable drug delivery pumps
10/20/2005DE20221397U1 Transdermal-Pflaster zum Verabreichen von Fentanyl Transdermal patch for administering fentanyl
10/20/2005DE10393805T5 Pharmazeutische Formulierungen, die ß-2-Adrenorezeptor-Agonisten und Xantine enthalten Included Pharmaceutical formulations beta-2-adrenoreceptor agonists and Xantine
10/20/2005CA2829943A1 Ion binding compositions
10/20/2005CA2806465A1 Ion binding polymers and uses thereof
10/20/2005CA2604878A1 Medicament for relief of symptoms of joint disorders and inflammatory conditions
10/20/2005CA2563276A1 Composition comprising colony stimulating factor for treatment of a localised bacterial infection and bacterial related disease
10/20/2005CA2563271A1 Solid products with improved stability and method for producing the same
10/20/2005CA2563150A1 Coating compositions for bioactive agents
10/20/2005CA2562018A1 Bioactive stents for type ii diabetics and methods for use thereof
10/20/2005CA2561933A1 Orally administered pharmaceutical composition
10/20/2005CA2561918A1 Preparation for oral administration
10/20/2005CA2561856A1 Compressed composition comprising magnesium salt
10/20/2005CA2561855A1 Taste-masked drugs in rupturing multiparticulates
10/20/2005CA2561619A1 Compositions with reduced hepatotoxicity
10/20/2005CA2561191A1 Microparticles for cell delivery
10/20/2005CA2560995A1 Controlled release dosage for gaba receptor agonist
10/20/2005CA2560724A1 Zinc preservative composition and method of use
10/20/2005CA2560312A1 Embolization
10/20/2005CA2559739A1 Deferasirox dispersible tablets
10/20/2005CA2558853A1 Polymer particles containing active agents
10/20/2005CA2558349A1 Pharmaceutical preparation containing drospirenone for application to the skin
10/20/2005CA2557848A1 Ion binding compositions
10/20/2005CA2557448A1 Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases
10/20/2005CA2556461A1 Spray dried pharmaceutical compositions
10/19/2005EP1586575A2 Salt of a sulfonic acid containing clopidogrel and use thereof for the preparation of pharmaceutical compositions
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1586557A1 4-nitro-2- (4 -methoxy)-phenoxy -methanesulfonanilide derivates and their pharmaceutical use
10/19/2005EP1586512A1 Packaging system for transdermal drug delivery systems
10/19/2005EP1586349A1 Controlled release of anti-arrhythmic agents
10/19/2005EP1586336A1 Compositions containing copper salts and soy products
10/19/2005EP1586329A1 Botulinum toxin pharmaceutical compositions
10/19/2005EP1586324A1 Ophthalmic therapeutic composition
10/19/2005EP1586316A1 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/19/2005EP1586315A1 Skin lightening composition
10/19/2005EP1586314A1 Nateglinide tablet composition
10/19/2005EP1586313A1 Pharmaceutical composition with metoclopramide and process for its preparation
10/19/2005EP1586311A2 Melt extrusion of multiparticulates
10/19/2005EP1586310A1 Method to manufacture valsartan adsorbates in the form of a free-flowing powder
10/19/2005EP1586309A1 Polymeric delivery formulations of leuprolide with improved efficacy
10/19/2005EP1586284A1 Induction of immunological tolerance
10/19/2005EP1585965A2 Utilization of emulsion interface engineering to produce oxidatively stable lipid delivery systems
10/19/2005EP1585902A2 Improved determination of gas solubility, entrained gas content, and true liquid density in manufacturing processes
10/19/2005EP1585592A1 Complex coacervate encapsulate comprising lipophilic core
10/19/2005EP1585585A2 Process and reactor for the manufacture of powders of inhalable medicaments
10/19/2005EP1585560A2 Delivery of molecules and complexes to mammalian cells in vivo
10/19/2005EP1585548A2 Compositions and methods of delivery of pharmacological agents
10/19/2005EP1585542A2 Immunogenic compositions containing phospholipid
10/19/2005EP1585519A1 High concentration formulations of opioids and opioid derivatives
10/19/2005EP1585512A1 Compositions and methods for improving the condition of patients suffering from copd and other diseases
10/19/2005EP1585506A1 Methods and compositions for wound management
1 ... 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 ... 2991